IDO-IN-19
IDO-IN-19 (Compound I) is a free base of an imidazole-isoindole derivative. IDO-IN-19 can inhibit the activity of Indoleamine 2,3-Dioxygenase (IDO) . IDO-IN-19 can block the decomposition of tryptophan and restore the function of T cells. IDO-IN-19 can be used for the researches of cancer, immunology, infection and neurological disease, such as breast cancer and Alzheimer's disease[1].
Product Specifications
CAS Number
2033173-20-3
UNSPSC
12352005
Target
Indoleamine 2,3-Dioxygenase (IDO)
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection; Inflammation/Immunology; Neurological Disease
Smiles
FC1=C2[C@H](C3CCN(C4=CC=C(C5=CN(N=C5)CCO)C=C4)CC3)N6C(C2=CC=C1)=CN=C6
Molecular Formula
C26H26FN5O
Molecular Weight
443.52
References & Citations
[1]Cao Xiaoli, et al. Crystalline form of free base of imidazo isoindole derivative and preparation method therefor. WO2018072742A1. 2018-04-26
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF740 conjugate, 0.1mg/mL
